Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Debt to Equity (2018 - 2025)

Health Catalyst (HCAT) has disclosed Debt to Equity for 8 consecutive years, with $0.46 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity fell 52.53% year-over-year to $0.46, compared with a TTM value of $0.46 through Sep 2025, down 52.53%, and an annual FY2024 reading of $1.05, up 68.46% over the prior year.
  • Debt to Equity was $0.46 for Q3 2025 at Health Catalyst, up from $0.44 in the prior quarter.
  • Across five years, Debt to Equity topped out at $1.05 in Q4 2024 and bottomed at $0.01 in Q2 2021.
  • Average Debt to Equity over 5 years is $0.58, with a median of $0.56 recorded in 2023.
  • The sharpest move saw Debt to Equity crashed 98.66% in 2021, then skyrocketed 4995.53% in 2022.
  • Year by year, Debt to Equity stood at $0.36 in 2021, then skyrocketed by 50.0% to $0.53 in 2022, then rose by 16.6% to $0.62 in 2023, then surged by 68.46% to $1.05 in 2024, then plummeted by 55.93% to $0.46 in 2025.
  • Business Quant data shows Debt to Equity for HCAT at $0.46 in Q3 2025, $0.44 in Q2 2025, and $1.02 in Q1 2025.